Sernova Biotherapeutics to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference
Jonathan Rigby and Will Rust, Ph.D., to Discuss Proposed Merger to Form BetaNova Biotherapeutics and Advance a Differentiated Type 1 Diabetes Cell-Replacement PlatformTORONTO and GERMANTOWN, Md., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics (“Sernova”) TSX:SVA OTC:SEOVF (FSE/XETRA: PS…